Phio Pharmaceuticals Corp Stock Investor Sentiment
| PHIO Stock | USD 2.65 0.60 18.46% |
About 56% of all Phio Pharmaceuticals' investors are looking to take a long position. The analysis of the overall investor sentiment regarding Phio Pharmaceuticals Corp suggests that some traders are interested. Phio Pharmaceuticals' investing sentiment overview a quick insight into current market opportunities from investing in Phio Pharmaceuticals Corp. Many technical investors use Phio Pharmaceuticals Corp stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Phio |
Phio Pharmaceuticals Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Phio Pharmaceuticals can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Far too much social signal, news, headlines, and media speculation about Phio Pharmaceuticals that are available to investors today. That information is available publicly through Phio media outlets and privately through word of mouth or via Phio internal channels. However, regardless of the origin, that massive amount of Phio data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Phio Pharmaceuticals news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Phio Pharmaceuticals relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Phio Pharmaceuticals' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Phio Pharmaceuticals alpha.
Phio Pharmaceuticals Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Phio Pharmaceuticals appoints Robert Infarinato as chief financial officer | 08/01/2024 |
2 | Phio Pharmaceuticals Announces Exploratory Collaboration with a Luxury Skin Care Company for Phios Patented INTASYL Compound | 08/06/2024 |
3 | Acquisition by Infarinato Robert M. of 8000 shares of Phio Pharmaceuticals subject to Rule 16b-3 | 08/13/2024 |
4 | Phio Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update | 08/14/2024 |
5 | Phio Pharmaceuticals Corp.s Path To Profitability | 08/27/2024 |
6 | Phio Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference | 09/09/2024 |
7 | Acquisition by Bradford Patricia A of 8000 shares of Phio Pharmaceuticals subject to Rule 16b-3 | 09/11/2024 |
8 | Acquisition by Lockshin Curtis of 2000 shares of Phio Pharmaceuticals subject to Rule 16b-3 | 09/12/2024 |
9 | Phio Pharmaceuticals Corp. Short Interest Down 47.2 percent in August | 09/13/2024 |
10 | PHIO - Phio Pharmaceuticals Corp. Latest Stock News Market Updates - StockTitan | 09/26/2024 |
11 | Phio Pharmaceuticals Presenting Data on Its INSTAYL Compound PH-894 at ASGCTs 2024 Advancing Gene and Cell Therapies for Cancer Conference | 10/16/2024 |
Check out Phio Pharmaceuticals Hype Analysis, Phio Pharmaceuticals Correlation and Phio Pharmaceuticals Performance. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Phio Pharmaceuticals. If investors know Phio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Phio Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (16.13) | Return On Assets (0.61) | Return On Equity (1.27) |
The market value of Phio Pharmaceuticals Corp is measured differently than its book value, which is the value of Phio that is recorded on the company's balance sheet. Investors also form their own opinion of Phio Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Phio Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Phio Pharmaceuticals' market value can be influenced by many factors that don't directly affect Phio Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Phio Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Phio Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Phio Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.